#Companion Animal Pharmaceutical Market SHARE

[globalinsightsservices]

Companion Animal Pharmaceutical Market is projected to expand at a steady CAGR over the forecast by 2031 | Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France).

Global Companion Animal Pharmaceutical Market report from Global Insight Services is the single authoritative source of intelligence on Companion Animal Pharmaceutical Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

The global companion animal pharmaceuticals market was valued at USD 12.9 billion in 2021 and it is anticipated to grow at a CAGR of 7.6% during the forecast period to reach up to USD 26.8 billion by 2031.

The rising adoption of pet animals due to growing urbanization and an increase in the number of nuclear families is among the primary market growth factors. A growing focus on animal health along with surging demand for pet insurance, especially in developed countries will augment the market expansion. The consistent rise in the number of diseases affecting animals is, in turn, generating demand for companion animal drugs. Additionally, industrial growth is attributable to the increasing incidence of zoonotic and food-borne diseases across the globe.

Get Free Sample Copy of This Report –https://www.globalinsightservices.com/request-sample/GIS10260

Market Trends and Drivers

The key factors such as the growing prevalence of zoonotic diseases is boosting the market growth during the forecast period. Some pathogens, such as zoonotic, can be transmitted from animals to humans. Examples of zoonotic diseases include rabies, salmonellosis, plague, brucellosis, and Lyme disease. Animals also share our susceptibility to certain diseases and environmental hazards and can serve as an early warning for potential human infections. Over the past two decades, the incidence of zoonotic diseases has increased across the globe, primarily as a result of the increased pet population. According to the International Livestock Research Institute (ILRI), 13 zoonoses cause 2.4 billion cases of human diseases and 2.2 million deaths every year. Toxoplasmosis—which is transmitted via cat feces—is quite common, with 10–20% of the UK population and 22% of the US population expected to carry the parasite as cysts. Cats with chronic bacteremia are primarily infected through saliva, and there is a high risk of transmittance from young adult cats. Although cats are asymptomatic carriers, weaker individuals can develop generalized infections. Many of the emerging and re-emerging infectious disease threats are vector-borne diseases transferred to animals and humans from arthropods.

Global Companion Animal Pharmaceutical Market Segmentation

The report analyses the global companion animal pharmaceutical market based on indication, animal type, distribution channel, and region.

Global Companion Animal Pharmaceutical Market by Indication

Based on indication, it is segmented into infectious diseases, dermatological diseases, orthopedic diseases, pain, behavioral disorders, and other indications. The dermatologic segment is likely0 to dominate the market during the forecast period. The increasing prevalence of arthritis coupled with the rising need for advanced orthopedic drugs, and the growing pet population are some key factors boosting the market growth.

Global Companion Animal Pharmaceutical Market by Animal Type

Based on animal type, it is segmented into dogs, cats, horses, and others. The dog segment is anticipated to dominate the market during the forecast period. The key factors such as the increasing dog’s population coupled with a rising ownership rate, increasing prevalence of zoonotic diseases and other skin allergies in dogs, rising canine healthcare expenditure, and the increasing number of pet insurers across the globe are boosting the market growth.

Global Companion Animal Pharmaceutical Market by Distribution Channel

Based on the distribution channel, it is segmented into veterinary hospitals, veterinary clinics, and retail pharmacies. The veterinary hospital segment is estimated to dominate the market during the forecast period. The key factors such as the animal parasiticides and antibiotics in hospital settings coupled with increasing incidence of infectious diseases, a growing number of veterinary hospitals, growing ownership of companion animals and increasing veterinary expenditure, and growing awareness about animal health in developing countries are some factors driving the growth of the segment.

Geographical Analysis of Companion Animal Pharmaceutical Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is likely to hold the major share of the market during the forecast period. The factors attributing to the growth of the market are a well-established base of animal health industries coupled with increasing incidences of parasitic infections, a large number of hospitals and clinics, a growing pool of veterinarians, and growing expenditure on animal health in the region. The growing number of research activities and funding and awareness campaigns in the field of veterinary health management is refueling the market growth.

Major Players in Companion Animal Pharmaceutical Market

The key factors in the global companion pharmaceutical market are Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK), Chanelle Pharma (Ireland), Kyoritsu Seiyaku (Japan), Zydus Animal Health and Investments Limited (India), Tianjin Ringpu Bio-Technology Co., Ltd. (China), HIPRA (Spain), Norbrook Holdings Limited (UK), Inovet (Belgium), Endovac Animal Health (US), ECO Animal Health Group plc (UK), Indian Immunologicals Ltd. (India), ALS Pvt. Ltd. (India), and Lutim Pharma Pvt. Ltd. (India).

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Excel data pack included with all report purchases

Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1–833–761–1700

Website:https://www.globalinsightservices.com/

[juanvmartinez2024]

Tailored Care for Furry Friends: Companion Animal Pharmaceuticals Market delivers specialized treatments for pets, addressing their unique healthcare needs and enhancing the well-being of beloved animal companions worldwide.

[animal-care]

Exploring Trends Shaping the Animal Care Market

The Animal Care Market is undergoing significant transformations driven by evolving consumer preferences, technological advancements, and emerging trends. In this article, we delve into the latest trends shaping the landscape of the animal care industry and their implications for market players.

Humanization of Pets: Treating Pets like Family

One of the prominent trends in the animal care market is the increasing humanization of pets. Pet owners are treating their animals more like family members, seeking products and services that cater to their pets' health, comfort, and emotional well-being. This trend has led to a growing demand for premium pet food, grooming services, and accessories designed to enhance the quality of life for companion animals.

Natural and Organic Products: A Shift towards Healthier Options

Consumers are becoming more conscious about the ingredients and materials used in pet care products, leading to a surge in demand for natural and organic alternatives. Pet owners are seeking products free from artificial additives, preservatives, and chemicals, opting instead for wholesome and sustainable options that promote the health and vitality of their pets. This trend has propelled the growth of natural pet food, eco-friendly toys, and biodegradable pet accessories in the market.

Telemedicine and Remote Veterinary Care: Convenient Healthcare Solutions

Advancements in technology have revolutionized the way veterinary care is delivered, with the adoption of telemedicine and remote monitoring solutions gaining traction in the animal care industry. Pet owners are increasingly turning to virtual consultations, telehealth platforms, and mobile apps to seek medical advice, diagnosis, and treatment for their pets, especially amid the COVID-19 pandemic. This trend has expanded access to veterinary services, improved convenience for pet owners, and facilitated early detection and intervention for pet health issues.

Personalized Nutrition and Wellness: Tailoring Care for Individual Pets

Pet owners are embracing personalized approaches to pet nutrition and wellness, recognizing that each animal has unique dietary and health needs. The demand for customized pet food formulations, tailored supplementation, and genetic testing services is on the rise as pet owners seek to optimize their pets' health and longevity. This trend has spurred innovation in the development of personalized pet nutrition plans, DNA testing kits, and health monitoring tools that cater to individual pets' requirements.

Sustainable and Ethical Practices

Environmental sustainability and ethical sourcing have become key considerations for pet owners when choosing products and services for their animals. There is a growing emphasis on eco-friendly packaging, cruelty-free ingredients, and ethical manufacturing practices in the animal care market. Companies are increasingly adopting sustainable initiatives, such as carbon-neutral operations, recyclable packaging, and ethical sourcing of raw materials, to align with consumer values and reduce their environmental impact.

Conclusion

The animal care market is evolving rapidly, driven by shifting consumer preferences, technological innovations, and societal trends. By staying attuned to these emerging trends and embracing innovation, companies can capitalize on new opportunities, differentiate their offerings, and meet the evolving needs of pet owners and their beloved companions. As the bond between humans and animals continues to strengthen, the animal care industry is poised for continued growth and transformation in the years to come.

[market-insider]

Veterinary Care Market Trends and Analysis: Comprehensive Overview of Market Size, Share, Growth

The global veterinary care market size is expected to reach USD 149.3 billion by 2030, registering at a CAGR of 8.0% over the forecast period, as per the new report by Grand View Research, Inc. Increasing number of government initiatives to safeguard food security is likely to boost the adoption of better veterinary care worldwide. A significant increase in pet adoption and humanization worldwide is mostly responsible for the high need for veterinary care, which is boosting the market growth.

Veterinary Care Market Report Highlights

Companion animals held the dominant share in the animal type segment owing to increasing pet healthcare expenditure and increasing pet adoption

The production animals segment is expected to register the fastest CAGR over the forecast period due to increasing government initiatives to improve livestock health

Moreover, rising domestic production, consumption, and export of bovine meat is boosting the segment growth

Primary care type, for both production & companion animals, dominated the global market in 2020 due to the increased pet ownership, government initiatives to prevent various animal diseases, and a high number of veterinary hospitals & clinics

For More Details or Sample Copy please visit link @: Veterinary Care Market Report

Moreover, the COVID-19 pandemic resulted in increased adoption of pets. In June 2020, at the Society for the Prevention of Cruelty to Animals Los Angeles, pet adoptions were double their normal rate, with almost 10 or 13 adoptions a day. Furthermore, a waiting list had formed for certain types of canines and puppies, as so few were left. Increasing awareness among pet owners for primary check-ups of their pets is further boosting the market.

The demand for animal protein is growing across the globe owing to higher per capita income. According to the article OECD-FAO Agricultural Outlook 2020-2029, growth in consumption of meat in the next decade is expected to increase by 12% by 2029. As the demand for meat continues to increase, the demand for veterinary care is anticipated to grow rapidly. Key companies in the market are collaborating with animal welfare organizations to encourage awareness and advance veterinary healthcare, which is further bolstering the market growth.

List of major companies in the Veterinary Care Market

Zoetis Inc.

Merck & Co., Inc.

Boehringer Ingelheim International GmbH

Elanco Animal Health Inc.

IDEXX Laboratories, Inc.

Ceva Santé Animale S.A.

Dechra Pharmaceuticals PLC

Virbac S.A.

Vetoquinol S.A.

Phibro Animal Health Corp.

For Customized reports or Special Pricing please visit @: Veterinary Care Market Analysis Report We have segmented the global veterinary care market on the basis of animal type, type of care, and region.

[heathcareforallworld]

Global Selamectin Market: Growth, Trends, and Forecast to 2032

Introduction

The global Selamectin market is poised for significant growth over the next decade, driven by increasing awareness regarding pet healthcare, the rising incidence of parasitic infections in animals, and expanding applications of veterinary drugs. Selamectin, a veterinary antiparasitic medication, is used to treat and prevent infestations by a variety of parasites, including fleas, heartworms, ear mites, and intestinal worms in cats and dogs. This article will explore the size, share, industry trends, and forecast for the Selamectin market through 2032.

Market Size and Share

Global Market Size

Selamectin Market Size was estimated at 1.94 (USD Billion) in 2023. The Selamectin Market Industry is expected to grow from 2.05(USD Billion) in 2024 to 3.2 (USD Billion) by 2032. The selamectin Market CAGR (growth rate) is expected to be around 5.73% during the forecast period (2024 - 2032). The increasing demand for veterinary pharmaceuticals, particularly in developed regions like North America and Europe, is a key driver of market expansion.

Regional Market Share

The Selamectin market is segmented into several regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America dominates the market with the largest share, accounting for over 35% of the total market in 2023. The high adoption of companion animals, coupled with advanced veterinary healthcare infrastructure, contributes to this dominance. The United States and Canada are the primary markets in this region.

Europe is the second-largest market for Selamectin, with a strong presence in countries like Germany, the UK, and France. Increasing awareness about pet healthcare and the rising prevalence of parasitic infections in pets fuel market growth in this region.

Asia Pacific is expected to be the fastest-growing region during the forecast period, driven by the rising pet ownership rate in countries like China, India, and Japan. Growing disposable income, coupled with increased awareness regarding pet health, is creating lucrative opportunities for the Selamectin market in this region.

Industry Trends

1. Increasing Pet Ownership One of the key trends driving the Selamectin market is the increasing pet ownership globally. As more households adopt companion animals, the demand for veterinary healthcare products, including antiparasitic medications like Selamectin, is rising. This trend is particularly pronounced in developed regions such as North America and Europe.

2. Rising Incidence of Parasitic Infections Another significant trend is the increasing prevalence of parasitic infections in pets, such as flea infestations, heartworm disease, and ear mite infections. As pet owners become more aware of the risks associated with parasitic infestations, they are increasingly seeking effective treatments and preventive measures, which is driving demand for Selamectin.

3. Advancements in Veterinary Pharmaceuticals Technological advancements in veterinary pharmaceuticals are also contributing to market growth. Companies are investing in the development of new formulations and delivery methods to enhance the efficacy and safety of Selamectin. This has led to the introduction of innovative products that offer extended protection against parasites with a single dose.

4. Growing Focus on Preventive Healthcare The trend toward preventive healthcare in pets is gaining momentum. Veterinarians and pet owners are increasingly focusing on preventive treatments to avoid costly medical interventions down the line. Selamectin, with its broad-spectrum activity against multiple parasites, is well-positioned to benefit from this shift toward preventive care.

Forecast 2032

The Selamectin market is expected to continue its upward trajectory through 2032, driven by several key factors:

Expansion in Emerging Markets: The growing demand for pet healthcare products in emerging economies like India, China, and Brazil presents significant growth opportunities for the Selamectin market. These regions are experiencing rapid urbanization, increasing pet ownership, and rising disposable income levels, which are all contributing to market growth.

Product Innovation: Ongoing research and development activities focused on improving the efficacy and safety of Selamectin products are expected to drive market growth. Companies are exploring new formulations, such as topical and oral solutions, to cater to the diverse needs of pet owners.

Regulatory Approvals: Favorable regulatory policies for veterinary drugs, particularly in North America and Europe, will support the market’s growth. The approval of new Selamectin products by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) will further boost market expansion.

Challenges

Despite the promising growth prospects, the Selamectin market faces certain challenges. The high cost of veterinary treatments and medications, particularly in developing regions, may limit market penetration. Additionally, the availability of alternative antiparasitic drugs poses a competitive challenge to Selamectin's market share.

Conclusion

The global Selamectin market is set for steady growth, driven by rising pet ownership, the increasing prevalence of parasitic infections, and advancements in veterinary pharmaceuticals. While North America and Europe remain dominant markets, Asia Pacific is expected to emerge as a significant growth region over the forecast period. By 2032, the Selamectin market will likely see continued innovation, expansion into emerging markets, and increasing adoption of preventive pet healthcare solutions.

[devan-patel]

Innovative Pet Care: Devan Patel's Natural Solutions

Devan Patel Pharmacist: For pharmacist Devan Patel, the entrepreneurial journey comes from a singular driving force – using the power of natural medicine to promote healing and well-being in both humans and their cherished animal companions. Over his two decades in pharmacy, Devan witnessed how traditional medications sometimes fell short, prompting him to explore alternative botanical therapies.

“I saw natural supplements truly transform my patients’ quality of life, especially those battling complex, multi-symptom conditions,” Devan recounts. “The limitations of mainstream healthcare inspired me to develop therapeutic nutraceuticals and plant-based compounds grounded in rigorous science.” 

This passion for innovative natural remedies led Devan to co-found Zen Nutrients, a company dedicated to creating pharmacist-doctor-formulated supplements backed by evidence-based research, such as The Everyday Liver Vitamin™ with Bergacyn® FF that aims to provide Fatty Liver Support & Liver Health Aid. As a devoted family man with a supportive wife and children, Devan strives to embody the same values of hard work, integrity, and compassion for others instilled in him by his parents.

“From a young age, my wonderful parents taught me the importance of diligence, honesty and genuinely caring about people’s wellbeing,” Devan shares. “Those lessons have guided me as a pharmacist and now as an entrepreneur developing natural health solutions.”

But Devan’s entrepreneurial drive extends far beyond just crafting supplements. It’s a higher calling rooted in family, community, and an unrelenting quest to solve unmet medical needs.

One of Devan’s latest co-developed product innovations is WoundVite® for Dogs – a veterinary mastermind formulation designed to promote healing, strengthen hip and joint health, and support recovery in dogs after surgery or injury.

Co-developed with a surgical veterinarian along with Devan’s pharmaceutical expertise, this product is a game changer in the dog pet industry, being the only product on the market that helps with wound healing, surgery recovery, while also serving as a supreme anti-inflammatory formula for hip and joint maintenance care.

After WoundVite® launched, Devan began hearing stories from dog owners who had given the supplement to their pets – often without their veterinarian’s knowledge about the natural product. To the owners’ surprise and delight, WoundVite® helped their dogs recover from injuries, surgeries and even strengthening their hip and joints in ways they hadn’t found with traditional medications and common dog supplements.

“As a lifelong dog lover who grew up adopting a dog, I’ve been able to see the challenges pet owners face. My own dog suffered from hip dysplasia associated with degenerative joint disease and osteoarthritis, leading me to witness firsthand the unmet need for effective solutions to help with their pain and suffering post surgery. It inspired me to create a product that could truly support our four-legged friends in their times of need,” Devan adds.

Masterfully blending 26 key vitamins, minerals, and herbs like glucosamine, MSM, turmeric, green lipped mussel, hemp seed, bovine collagen, vitamins E, zinc, and C, WoundVite® aims to aid in reducing inflammation, promoting wound recovery, and providing building blocks for the repair of cartilage, connective tissue, and joints. The innovative part is that it also contains a proprietary recovery blend of omega fatty acids, hyaluronic acid, grape seed extract, l-arginine, astaxanthin all co-formulated by a surgical veterinarian to optimize healing and recovery.

“Seeing the impact our science-backed, natural products have on improving lives is immensely gratifying,” Devan states. “It motivates me to keep innovating so we can overcome seemingly intractable health issues across all species.”

While a work in progress, Devan’s ultimate vision along with her core team is for Zen Nutrients’ therapeutic nutraceutical line – including WoundVite® for pets – to be carried by major retailers.

With botanical innovations, integrity, and a passion for preventing and managing chronic conditions, Devan Patel and Zen Nutrients are pioneering the future of integrative health. By synergizing pharmaceutical science with the wisdom of natural medicine, this “pharmapreneur” is pioneering a path forward for the wellness of millions across all species.

Reference link: https://nyweekly.com/business/pharmapreneur-devan-patel-natural-solutions-for-pets/

[prajwal-agale001]

Pet Oral Care Market Projected for Significant Growth Driven by Innovation and Rising Pet Ownership

According to the latest report from Meticulous Research®, the global pet oral care market is projected to achieve a value of $3 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.1% over the forecast period. This growth is primarily fueled by increasing pet ownership, rising pet-related expenditures, the expanding pet insurance market, and a heightened prevalence of dental issues among pets.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=2692

Market Overview and Segmentation

The pet oral care market is segmented by product type, animal type, sales channel, and geography.

Product Segmentation: The market includes toothpaste, toothbrushes, mouthwash, dental chews, additives, and other oral care products. The dental chews segment is anticipated to experience the highest growth rate during the forecast period, driven by ongoing innovations in ingredient formulations and the launch of new products. For example, in January 2024, Clear Conscience Pet (U.S.) introduced a new chew that incorporates the plaque-preventive benefits of kelp. Additionally, the convenience of dental chews compared to traditional brushing methods is contributing to their increasing adoption.

Animal Type Segmentation: By 2024, the dog segment is expected to hold the largest share of the pet oral care market. This dominance is attributed to the widespread adoption of dogs as pets globally and growing awareness of pet oral health, particularly in developed regions.

Sales Channel Segmentation: The market is divided into online and offline channels. The online segment is projected to see the highest growth rate, driven by increasing awareness about pet health in developing countries, higher pet health expenditures, and the convenience of purchasing oral care products through online platforms.

Geographic Insights

The report provides a detailed analysis of major geographic regions:

North America: Expected to dominate the pet oral care market in 2024, with the U.S. leading the region. Factors contributing to North America's market share include high pet health expenditures, substantial disposable incomes, a large pet population, and strong awareness of companion animal health.

Europe: Following North America, Europe is projected to hold a significant share, driven by increasing pet care awareness and spending across key countries such as Germany, France, the U.K., Italy, and Spain.

Asia-Pacific: This region is expected to show robust growth, fueled by rising pet adoption rates, increasing disposable incomes, and growing investment in pet health.

Key Industry Players

The pet oral care market is moderately competitive, with several prominent players including:

Boehringer Ingelheim International GmbH (Germany)

VETOQUINOL S.A. (France)

AllAccem, Inc. (U.S.)

Petzlife UK (U.K.)

Dechra Pharmaceuticals PLC (U.K.)

imRex Inc. (Canada)

Nestlé S.A. (Switzerland)

Mars, Incorporated (U.S.)

Ceva Animal Health, LLC (U.S.)

Virbac S.A. (France)

Hill's Pet Nutrition, Inc. (U.S.)

Conclusion

The pet oral care market is poised for significant expansion, driven by increased pet ownership, higher expenditures on pet health, and innovations in oral care products. While North America remains the largest market, strong growth is anticipated in Asia-Pacific and Europe. The continued focus on improving pet health and convenience is expected to drive the market forward, presenting ample opportunities for industry players and stakeholders.

Read Full Report:- https://www.meticulousresearch.com/product/pet-oral-care-market-2692?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=11-09-2024 Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

[creativeera]

The Middle East and Africa Animal Healthcare Market is Poised for Exponential Growth driven by Rising Pet Ownership

The Middle East and Africa animal healthcare market comprises products such as vaccines, pharmaceuticals, and feed additives used for disease prevention and treatment in livestock animals. The demand for animal healthcare products is increasing due to rising awareness about zoonotic diseases and quality animal proteins. Advances in veterinary medicine and growth of the companion animal market have also fueled the demand for veterinary services and healthcare products in the region.

The Global Middle East and Africa Animal Healthcare Market is estimated to be valued at US$ 5478.77 Bn in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the Middle East and Africa animal healthcare market are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichem Laboratories, Arevipharma GmbH, Resonance-labs, Sun Pharmaceutical Industries Ltd., Rusan Pharma, Micro Orgo Chem, and Faran Shimi Pharmaceutical Co. These companies are actively focusing on product innovations and expansion strategies to consolidate their market presence. The Middle East And Africa Animal Healthcare Market Demand for animal healthcare products is driven by rising pet ownership and growing consumption of animal-derived food products in the region. Various public and private organizations are undertaking initiatives to promote responsible pet ownership and prevent the spread of zoonotic diseases. Major animal healthcare companies are augmenting their production capacities and distribution networks across Middle Eastern and African countries. Strategic partnerships with local players help global companies to strengthen their supply chain and improve access to remote and rural areas. Collaboration with veterinary bodies and livestock industry associations also help gain consumer trust and market penetration. Market Key Trends The Middle East And Africa Animal Healthcare Market Size and Trends of pet humanization is contributing to the growth of the companion animal healthcare market in the region.Pet owners are increasingly spending more on nutritious pet food, grooming products, accessories, insurance, and advanced medical care. Growing pet obesity and lifestyle diseases have also increased the demand for therapeutic diet food and nutraceuticals for companion animals. E-commerce platforms are further facilitating the accessibility of diverse pet care products in the region.

Porter’s Analysis Threat of new entrants: High capital requirements and ongoing R&D investments of new drugs pose substantial barriers to entry. Bargaining power of buyers: Buyers have moderate bargaining power as there are many established brands to choose from. Bargaining power of suppliers: Suppliers of raw materials and components have moderate bargaining power due to differentiated inputs required. Threat of new substitutes: Threat of new substitutes is moderate as alternative treatment options are available in case of non-performance or high prices. Competitive rivalry: Intense competition exists among existing players to gain market share through product differentiation, marketing activities and competitive pricing. Geographical Regions The Middle East and Africa animal healthcare market in terms of value is currently concentrated in countries like Saudi Arabia, South Africa, and Egypt. Rapid urbanization and rising pet ownership are driving the demand for animal healthcare products in these countries. South Africa accounts for over 25% of the total market value in the region currently due to strong beef and dairy industries. The fastest growing geographical region for the Middle East and Africa animal healthcare market is expected to be West Africa over the forecast period 2024 to 2031. Countries like Nigeria, Ghana, and Ivory Coast are projected to witness double-digit growth rates during this period led by rising livestock production, increasing awareness about animal diseases, and growing veterinary healthcare infrastructure in the region. Economic development and changing diets are supporting the expansion of the livestock sector which is supporting the animal healthcare market growth.

Get more insights on Middle East And Africa Animal Healthcare Market

Unlock More Insights—Explore the Report in the Language You Prefer

French

German

Italian

Russian

Japanese

Chinese

Korean

Portuguese

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)

[trendtrackershq]

How Ceva Santé Animale is Shaping the Future of the Animal Vaccines Market

Introduction

Ceva Santé Animale, a global leader in animal health, is making significant strides in the Animal Vaccines Market. Known for its innovative approaches and commitment to improving animal health, Ceva is at the forefront of developing advanced vaccines and shaping market trends. This article explores how Ceva Santé Animale is influencing the animal vaccines market through strategic initiatives, emerging innovations, and recent developments.

Download FREE Sample: https://www.nextmsc.com/animal-vaccines-market/request-sample

Company Overview

Ceva Santé Animale, headquartered in Libourne, France, is a major player in the global animal health industry. Founded in 1999, the company has grown rapidly and now operates in over 110 countries. Ceva’s portfolio includes vaccines, pharmaceuticals, and feed additives for both companion animals and livestock.

Strategic Initiatives

Expansion Through Strategic Acquisitions

Ceva has adopted a proactive acquisition strategy to enhance its capabilities and market reach. By acquiring established companies and emerging players in the animal health sector, Ceva strengthens its product portfolio and expands its geographical footprint.

Recent Acquisitions: Notable acquisitions include the purchase of the veterinary vaccine division of the Danish company, Boehringer Ingelheim, and the acquisition of the animal health business of the French company, Virbac. These acquisitions have bolstered Ceva’s vaccine offerings and provided access to new markets.

Strategic Goals: These acquisitions align with Ceva’s goal to broaden its range of vaccines and enhance its global presence. By integrating complementary technologies and expertise, Ceva positions itself as a leader in innovative animal health solutions.

Investment in Research and Development

Ceva places a strong emphasis on research and development (R&D) to drive innovation and address emerging health challenges. The company invests heavily in R&D to develop new vaccines, improve existing formulations, and explore novel therapeutic approaches.

Innovation Centers: Ceva has established dedicated R&D centers focused on vaccine development. These centers work on creating vaccines for a wide range of diseases, from common conditions to emerging threats.

Collaborative Research: The company collaborates with academic institutions, research organizations, and other industry players to advance vaccine technology and share knowledge. This collaborative approach accelerates the development of cutting-edge vaccines and ensures that Ceva remains at the forefront of innovation.

Emerging Innovations

Development of Next-Generation Vaccines

Ceva is actively involved in the development of next-generation vaccines that offer improved efficacy, safety, and convenience. These innovations aim to address both existing and emerging disease threats in companion animals and livestock.

Recombinant Vaccines: Ceva is advancing the use of recombinant vaccine technology, which involves genetically modifying microorganisms to produce antigens. This approach enhances the precision and effectiveness of vaccines, targeting specific pathogens with greater accuracy.

DNA and mRNA Vaccines: The company is exploring the potential of DNA and mRNA vaccine technologies, which offer rapid development and adaptability to new and evolving pathogens. These technologies are expected to revolutionize vaccine development by providing flexible and effective solutions.

Needle-Free Vaccination Solutions

To improve vaccine administration and reduce stress for animals, Ceva is investing in needle-free vaccination technologies. These solutions offer a more comfortable and efficient way to deliver vaccines, especially in large-scale animal populations.

Jet Injectors: Needle-free jet injectors are being developed to administer vaccines without needles. This technology uses high-pressure streams to penetrate the skin, providing a painless and quick vaccination process.

Oral Vaccines: Ceva is also working on oral vaccine formulations that can be administered through feed or water. Oral vaccines simplify the vaccination process, especially for livestock, and enhance compliance in mass vaccination programs.

Inquire before buying: https://www.nextmsc.com/animal-vaccines-market/inquire-before-buying

Recent Developments

Launch of New Vaccine Products

Ceva has recently introduced several new vaccine products to address critical health issues in animals. These vaccines reflect the company’s commitment to innovation and its response to evolving health challenges.

Vaccine for Canine Parvovirus: Ceva launched a new vaccine for canine parvovirus, a highly contagious and potentially fatal disease. This vaccine offers enhanced protection and has been well-received by veterinarians and pet owners.

Poultry Vaccines: The company has expanded its poultry vaccine portfolio to include new products targeting avian influenza and Newcastle disease. These vaccines are designed to improve flock health and support the poultry industry’s biosecurity efforts.

Global Expansion and Market Penetration

Ceva is focusing on expanding its market presence, particularly in emerging regions. The company is strengthening its distribution networks and building partnerships to increase access to its vaccines and other animal health products.

Market Expansion: Ceva is targeting growth in key emerging markets such as Asia-Pacific, Latin America, and Africa. By investing in local operations and partnering with regional distributors, the company is enhancing its market reach and addressing the specific needs of these regions.

Local Production: To support its global expansion, Ceva is establishing local production facilities and enhancing its supply chain capabilities. This approach ensures timely availability of vaccines and reduces logistical challenges in delivering products to diverse markets.

Conclusion

Ceva Santé Animale is making a substantial impact on the animal vaccines market through its strategic initiatives, emerging innovations, and recent developments. By focusing on acquisitions, investing in R&D, and advancing vaccine technologies, Ceva is leading the way in improving animal health and addressing critical disease threats.

As the company continues to drive innovation and expand its global presence, it will play a crucial role in shaping the future of the animal vaccines market. Stakeholders in the animal health industry should closely monitor Ceva’s developments, as the company’s advancements will likely influence market trends and set new standards for vaccine efficacy and safety.

[nidarsanafwr]

Companion Animal Pharmaceuticals Market Analysis, Size, Share, and Forecast 2031

[bhushans]

Regional Analysis of the Companion Animal Specialty Drugs Market

The companion animal specialty drugs market is poised for significant expansion over the next decade. According to the latest projections, the market, valued at USD 37,624.67 million in 2022, is expected to reach a remarkable USD 56,828.56 million by 2032, with a moderate-paced compound annual growth rate (CAGR) of 4.21%.

The historical data indicates a robust CAGR of 5.42%, reflecting the growing demand for specialized medical treatments for companion animals. This trend underscores the increasing importance of veterinary pharmaceuticals in enhancing the health and wellbeing of pets worldwide.

Get your PDF Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3984

A major contributing element to the rise in sales and demand for animal nutrition and behavioral products is the rise in pet adoption. The need for anti-obesity medications has surged dramatically as a result of the rise in pet obesity over the past few years.

The COVID-19 epidemic and the ensuing worldwide shutdown in the first quarter of 2021 contributed to a rise in pet adoptions, especially of dogs and cats. Dog adoption is fairly common, particularly among senior citizens. It is anticipated that this will increase demand for skin care items, pet food, and medicines.

Key Takeaways

Urbanization and trend of nuclear families have been greatly helpful in increasing market share of companion animal drug market.

People have started considering pets as their family member and this led to increase in overall expenditure of a family, as a result this benefitted the companion market.

Increase in rising pet diseases have provided the industry with a positive push to manufacture more companion drugs to meet the demand

Industrial growth can likely be attributed to a rise food-borne and zoonotic diseases.

Increase in per capita income of urban population, have enabled people to take better care of their pets by means of diagnosis, vaccination, mitigation, and treatment of diseases such as kidney diseases, heartworms and Lyme diseases, which resulted in giving a boost for companion animal specialty drug market share.

COVID-19 had a positive impact on pet adoption rate, with a rise of 50% each year

Technological advancement has been a strong driving factor in market progression of companion animal drug market

Competitive Landscape

Extensive mergers and acquisitions, product portfolios, geographical expansions, and collaborative research initiatives are some of the strategies undertaken by the leading players. Established players in this market have made alliances with different companies to increase their market reach and social media presence. Some well-established players in the US companion animal drug specialty market are:

Merck Animal Health

Elanco

Zoetis

Vetiquinol S.A.

Virbac, Inc.

Norbrook Inc.

Dechra Pharmaceuticals

Patterson Companies, Inc.

Vedco Inc.

Covetrus

MWI Animal Health

Nutramax Laboratories Veterinary Sciences, Inc.

Ellevet Sciences

Recent Developments

In 2017, Zoetis emerged as a leading player with the highest share of compassion animal specialty drugs, as the company has a considerable and significant market presence, a diverse portfolio of product offerings, and an acute strategic perspective which includes M&As, such as the acquisition of Abaxis in 2018.

In July 2019, Zoetis and Colorado state university made an agreement to establish a research lab for the development of immunotherapies for veterinary patients.

In August 2020, Elanco Animal Health Incorporatedannounced that it has acquired Bayer Animal Health. The transaction was valued at USD 6.89 billion. This development helped the company to expand itself in the durable animal health industry.

Key Segments in the Companion Animal Specialty Drugs Market:

By Product:

Antibiotics

Anti-Inflammatory Drugs

Parasiticides

Heartworm

Behavioral Products

Nutritional Products

Anti-Obesity Drugs

Skin Care Products

Vaccines

By Distribution Channel:

Modern Trade

Online Distribution

Neighborhood Stores

Other Retail Format

By Region:

North America

Latin America

Asia Pacific

Middle East & Africa (MEA)

Europe

[industryforecastnews]

U.S. Veterinary Orthopedic Medicine Market Size, Share & Growth Analysis Report, 2030

U.S. Veterinary Orthopedic Medicine Market Growth & Trends

The U.S. veterinary orthopedic medicine market size is expected to reach USD 814.51 million by 2030, registering a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the increasing pet population, adoption of pet insurance, rising prevalence of diseases among animals, and advancements in veterinary medicine.

For instance, in October 2023, the FDA approved Librela (bedinvetmab injection), making it the first monoclonal antibody for treating osteoarthritis-related pain in dogs. In addition, in April 2022, American Regent Animal Health, a division of American Regent, Inc., received FDA approval to extend the shelf life of Adequan Canine and Adequan i.m. The expiration date for both products was increased from 24 months to 36 months from the date of manufacture.

Key players in the veterinary orthopedic medicine market are engaging in strategic initiatives like product launches, collaborations, and acquisitions to make their market presence more prominent, impelling market growth. In September 2022, Zoetis acquired Jurox, a private animal health company specializing in veterinary medicines for livestock and companion animals. The deal, finalized in August 2021, included Jurox's operations in Australia and regional offices in the U.S., Canada, and the UK. Such initiatives are anticipated to drive market growth.

For instance, in October 2023, Athersys, Inc. (ATHX), a cell therapy and regenerative medicine company, entered into a licensing agreement with Ardent Animal Health. With this move, Athersys, known for its work with MultiStem (invimestrocel) in critical care, entered the field of animal health. This collaboration with Ardent, a veterinary biotech firm specializing in regenerative medicine and cancer therapies for animals, highlights Athersys’ commitment to advancing veterinary care.    

Some key impacts of the pandemic and respective lockdowns on the market include dampened growth, decreased sales, supply chain disruptions, and operational challenges. However, the pandemic also propelled concerns over animal health and welfare, strengthened the pet parent and animal bond, and increased pet adoption. Moreover, the market witnessed an improved medicalization rate, pet expenditure, and adoption of pet insurance.

Increasing pet humanization and improved diagnostic rates were other positive impacts of the COVID-19 pandemic on the veterinary sector. In 2021, the market recorded increased demand and sale of veterinary medicines, including orthopedic medicines. In 2022, other macroeconomic uncertainties, such as global recession and cost inflation, adversely impacted the business. However, as the underlying market drivers remain unchanged owing to an increasing prevalence of orthopedic disorders in dogs and horses, the market is estimated to grow notably over the forecast period.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/us-veterinary-orthopedic-medicine-market-report

U.S. Veterinary Orthopedic Medicine Market Report Highlights

Based on product, pharmaceuticals segment dominated the market, accounting for a share of 46.72% in 2023. Pharmaceutical treatments for orthopedic diseases in pets, such as Non-steroidal Anti-inflammatory Drugs (NSAIDs) and pain relievers, have been widely used and established as effective treatments for managing pain and inflammation. On the other hand, the viscosupplements segment is anticipated to grow at the fastest CAGR of 8.23% during the forecast period

Based on animal type, the market is segmented into dogs and horses. The dogs segment dominated the market, accounting for a share of 51.98% in 2023. It is also anticipated to grow at the fastest CAGR of 7.80% in the coming decade

Based on application, the osteoarthritis segment accounted for the largest share of 60.65% of the market in 2023. The other segment is expected to grow at the fastest CAGR of 9.39% over the forecast period

Based on route of administration, the market is segmented into injectable, oral, and others (e.g., topical). The injectable segment dominated the market, accounting for a share of 60.40% in 2023. The others (e.g., topical) segment is anticipated to grow at the fastest CAGR of 8.22% in the coming decade

On the basis of end-use, veterinary clinics & hospitals segment accounted for the largest share of 53.59% of the market in 2023. The other segment is expected to grow at the fastest CAGR of 8.68% over the forecast period

U.S. Veterinary Orthopedic Medicine Market Segmentation

Grand View Research has segmented the U.S. veterinary orthopedic medicine market based on product, animal type, application, route of administration, and end-use:

U.S. Veterinary Orthopedic Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)

Biologics

Stem Cells

Platelet-Rich Plasma (PRP)

Other Biologics

Viscosupplements

Pharmaceuticals

Steroids

NSAIDS

Others

U.S. Veterinary Orthopedic Medicine Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

Dogs

Small Breeds

Medium Breeds

Large Breeds

Horses

U.S. Veterinary Orthopedic Medicine Application Outlook (Revenue, USD Million; 2018 - 2030)

Osteoarthritis

Degenerative Joint Disease

Others

U.S. Veterinary Orthopedic Medicine Route Of Administration Outlook (Revenue, USD Million, 2018 - 2030)

Injectable

Intra-Muscular

Intra-Articular

Others

Oral

Others

U.S. Veterinary Orthopedic Medicine End-use Outlook (Revenue, USD Million, 2018 - 2030)

Veterinary Hospitals & Clinics

At-home

Others

List of Key Players in the U.S. Veterinary Orthopedic Medicine Market

Zoetis Services LLC

Ardent Animal Health, LLC

Enso Discoveries

VetStem, Inc.

Contura Vet

PetVivo Holdings, Inc.

T-Cyte Therepeutics

Boehringer Ingelheim International GmbH

Arthrex, Inc.

MEDREGO LLC

Nucleus ProVets

Daiichi Sankyo Company, Limited 

Bimeda U.S.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/us-veterinary-orthopedic-medicine-market-report

[animal-care]

Exploring the Animal Care Market Revenue, Growth, and Future Outlook

Introduction

The Animal Care Industry plays a pivotal role in ensuring the health, well-being, and happiness of pets and companion animals worldwide. This article delves into the dynamics of the animal care market, offering insights into its research reports, growth prospects, revenue outlook, and emerging trends.

Animal Care Market Research Reports

Market research reports serve as valuable resources for understanding the animal care industry landscape. These reports provide comprehensive analyses of market trends, growth drivers, challenges, and opportunities. Recent studies indicate a positive outlook for the global animal care market, with substantial growth expected in the coming years.

Animal Care Market Forecast

The animal care market is poised for significant growth, driven by various factors contributing to increased demand for pet-related products and services. Market analysts project steady growth, with a compound annual growth rate CAGR of 4.3% expected between 2023 and 2033, reaching a market size of USD 62.3 billion by 2033.

Animal Care Market Size

The global animal care market was estimated at USD 40.9 billion in February 2024, reflecting robust growth in pet ownership and spending. In the United States alone, the market was valued at USD 136.8 billion in 2022, according to the American Pet Products Association.

Animal Care Market Growth

While the global animal care market is experiencing steady growth, the United States is anticipated to witness a growth rate of 2-3% in 2024, as per Grand View Research. This growth is fueled by factors such as increasing disposable income, rising pet ownership, and growing awareness of animal well-being.

Market Segments

The animal care market comprises several segments catering to the diverse needs of pet owners:

Pet Food & Treats

This segment holds the largest share of the global market, accounting for approximately 50% of total spending on animal care products.

Pet owners are increasingly opting for premium pet food and treats, driving growth in this segment.

Veterinary Care & Products

The veterinary care segment is the second-largest, with projections suggesting it might reach USD 37 billion in the US by 2023.

Advancements in veterinary medicine and increased spending on preventive healthcare contribute to the segment's growth.

Supplies, Live Animals & Over-the-counter Medications

Estimated at USD 32.1 billion in the US in 2023, this segment encompasses a wide range of products, including pet supplies, live animals, and over-the-counter medications. This segment includes pet insurance, boarding, grooming, and training services, estimated at USD 11.8 billion in the US in 2023.

Market Trends

Several notable trends are reshaping the Animal Care Market:

Premiumization- Pet owners are increasingly willing to invest in premium pet food, treats, and healthcare options, reflecting a growing focus on pet well-being and nutrition.

Surge in Pet Adoptions- The pandemic-driven surge in pet adoptions continues to influence market demand, with more households welcoming pets into their lives.

Direct-to-Consumer Channels- Online pet food and medication deliveries are witnessing significant growth, driven by the convenience and accessibility offered by direct-to-consumer (D2C) channels.

Focus on Sustainability- Environmentally friendly pet products and services are gaining popularity as consumers become more conscious of their ecological footprint.

Conclusion

The animal care market presents lucrative opportunities for industry players, driven by increasing pet ownership, rising spending on pet-related products and services, and evolving consumer preferences. By staying abreast of market trends, investing in research and development, and embracing sustainable practices, stakeholders can capitalize on the growing demand for animal care solutions, contributing to the well-being of pets and companion animals worldwide.

[market-insider]

Veterinary Clinical Trials Market Future Outlook: Analyzing Size, Share, and Growth Patterns

The global veterinary clinical trials market size is expected to reach USD 8.99 billion by 2030, exhibiting a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving industry growth include increased R&D expenditure by key players, rising prevalence of chronic diseases in animals, advancements in veterinary medicines, and rise in strategic alliances. For instance, in April 2024, Boehringer Ingelheim, a biopharmaceutical company focused on both human and animal health invested USD 593.5 Mn in animal health R&D to accelerate veterinary clinical trials as well as to develop innovative veterinary medicine.

Veterinary Clinical Trials Market Report Highlights

Ongoing advancements in veterinary medicine drive the demand for veterinary clinical trials to improve animal health and welfare. Additionally, growing R&D investments by key players to innovate veterinary medicine are expected to boost market demand.

By animal type,companion animal segment dominated the market in 2023 and is projected to witness the fastest growth rate of 9.5% in the coming years. Furthermore, among companion animals, canines segment is holding highest market share in 2023.

In terms of indication, oncology segment dominated the market with a share of 27.51% in 2023, owing to the rising prevalence of cancers in animals and growing R&D investment for veterinary oncology. Whereas internal medicine segment is expected to grow at the fastest rate of over 10.2% in the coming years.

Based on the sponsor, pharmaceutical and biopharmaceutical companies segment dominated the market in 2023, and the academics and research centers segment is expected to grow at the fastest rate of over 9.8% in the coming years.

Medicines accounted for the largest market share by intervention type in 2023. However, medical device segment is estimated to witness the highest growth rate of around 10.0% in the near future.

In 2023, North America held the highest share of 33.70% of the market by region.The Asia Pacific region is expected to grow at the fastest rate of over 10.1% in the coming years.

For More Details or Sample Copy please visit link @: Veterinary Clinical Trials Market Report

Additionally, an increasing number of clinical trials for rare diseases in pets is expected to drive veterinary clinical trial market. Veterinary clinics and research institutions are undertaking specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques designed for individual dogs' genetic profiles. For instance, in March 2024, Vivesto AB initiated its Paccal Vet clinical trial for dogs with splenic hemangiosarcoma, marking a significant step toward addressing this challenging cancer type in canines. The trial aims to assess the safety and efficacy of Paccal Vet, formulated with XR-17 technology, with promising results potentially leading to further pivotal studies.

There is a growing focus on preventive care in veterinary medicine. Clinical trials aimed at developing preventive treatments, such as vaccines and early diagnostic tools, are becoming more common. Furthermore, veterinary clinics and research institutions are launching specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques tailored to individual dogs' genetic profiles.

List of Key Players in the Veterinary Clinical Trials Market

Charles River Laboratory

IDEXX Laboratories, Inc.

Boehringer Ingelheim International GmbH.

Argenta

Bioagile Therapeutics Pvt. Ltd.

Veterinary Research Management

Merck & Co., Inc.

Labcorp Drug Development

OCR - Oncovet Clinical Research

Vivesto AB

Vetbiolix

[lalsingh228-blog]

Animal Biotechnology Market: Ready To Fly on high Growth Trends

Global Animal Biotechnology Market Report from AMA Research highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, player’s market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved profitability. In addition, the study helps venture or private players in understanding the companies in more detail to make better informed decisions. Major Players in This Report Include, Roche Holding AG (Switzerland), Bayer AG (Germany), Biogenesis Bago (Argentina), Boehringer Ingelheim (Germany), Merck & Co., Inc. (United States), Pfizer Inc. (United States), Santa Cruz Biotechnology, Inc. (United States), Virbac (France), Zoetis Inc. (United States), Johnson & Johnson (United States). Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/83766-global-animal-biotechnology-market Animal biotechnology is a branch of biotechnology in which molecular biology techniques are used to genetically engineer living organisms in order to improve their suitability for pharmaceutical, agricultural or industrial applications. It involves all animals such as livestock, poultry, fish, insects, companion animals and laboratory animals. Animal biotechnology helps to improve animal health and welfare, advancement in human health, enhancements in animal products, environmental and conservation benefits. With the help of this technology, farmers can enhance breeding to produce healthier herds. It also helps to prevent and treat animal disease. Improved animal health results in safer foods for consumers. The animal products such as meat, milk and eggs can be nutritionally enriched with the use of this technology. It also helps to produce environmentally friendly animals as well as conserve endangered species. Market Drivers

Increased Applications of the Animal Biotechnology in Various Fields

Advancements in the Cloning and Development of Transgenic Animals

Rise in the Demand for Transgenic Animals

Increased Research and Development Activities

Market Trend

Introduction of Use of Animal Organs in Human Transplant Operations

Opportunities

Favorable Government Policies for Animal Biotechnology Applications

Growing Demand from the Pharmaceutical Industry

Huge Investments by Major Players

Challenges

Introduction of Transgenic May Affect the Direction of Evolution and Eventually Decrease the Gene Pool

Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/83766-global-animal-biotechnology-market In this research study, the prime factors that are impelling the growth of the Global Animal Biotechnology market report have been studied thoroughly in a bid to estimate the overall value and the size of this market by the end of the forecast period. The impact of the driving forces, limitations, challenges, and opportunities has been examined extensively. The key trends that manage the interest of the customers have also been interpreted accurately for the benefit of the readers. The Animal Biotechnology market study is being classified by Type (Animal Genomics, Animal Cloning, Genetic Engineering of Animals), Application (Preventive Care for Animals, Development of Animal Pharmaceuticals, Food Safety and Drug Development, Others), Products (Animal Products, Vaccines, Drugs, Others) The report concludes with in-depth details on the business operations and financial structure of leading vendors in the Global Animal Biotechnology market report, Overview of Key trends in the past and present are in reports that are reported to be beneficial for companies looking for venture businesses in this market. Information about the various marketing channels and well-known distributors in this market was also provided here. This study serves as a rich guide for established players and new players in this market. Get Reasonable Discount on This Premium Report @ https://www.advancemarketanalytics.com/request-discount/83766-global-animal-biotechnology-market Extracts from Table of Contents Animal Biotechnology Market Research Report Chapter 1 Animal Biotechnology Market Overview Chapter 2 Global Economic Impact on Industry Chapter 3 Global Market Competition by Manufacturers Chapter 4 Global Revenue (Value, Volume*) by Region Chapter 5 Global Supplies (Production), Consumption, Export, Import by Regions Chapter 6 Global Revenue (Value, Volume*), Price* Trend by Type Chapter 7 Global Market Analysis by Application ………………….continued This report also analyzes the regulatory framework of the Global Markets Animal Biotechnology Market Report to inform stakeholders about the various norms, regulations, this can have an impact. It also collects in-depth information from the detailed primary and secondary research techniques analyzed using the most efficient analysis tools. Based on the statistics gained from this systematic study, market research provides estimates for market participants and readers. Contact US : Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[petnews2day]

Companion Animal Pharmaceuticals Market Size Set to Touch USD 45.12 Billion With the CAGR of 4.42% by 2029

New Post has been published on https://petn.ws/FfO1U

Companion Animal Pharmaceuticals Market Size Set to Touch USD 45.12 Billion With the CAGR of 4.42% by 2029

BlueWeave Consulting and Research Pvt Ltd North America held the highest market share, due to the increasing number of pets, greater pet expenditure, and the trend towards pet humanization. Also, there has been a significant increase in pets receiving medical care, particularly for cats, following the start of the COVID-19 pandemic. Meanwhile, the Asia-Pacific region […]

See full article at https://petn.ws/FfO1U #PetFinancialNews